{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:30:43Z","timestamp":1791243043534,"version":"4.1.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>Patients with Crohn\u2019s disease (CD) exhibit excessive apoptosis of intestinal epithelial cells (IECs), which contributes to damage to the intestinal barrier structure and function, thereby playing a role in the progression of colitis. Preventing IEC apoptosis and protecting the intestinal barrier are critical to alleviating colitis. Natural plant monomers have been reported to possess multiple pharmacological properties, particularly with the potential to treat CD. This study focuses on Cynaroside (Cyn) to explore its effect on IEC apoptosis and evaluate its pharmacological impact on the intestinal barrier and colitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced CD-like colitis mice model was employed in this study. We assessed the therapeutic effect of Cyn on CD-like colitis by evaluating the disease activity index (DAI), body weight changes, intestinal tissue pathological damage, and inflammatory factor levels. Immunofluorescence and Western blotting were used to detect the expression and localization of tight junction (TJ) proteins, allowing us to analyze the intestinal barrier structure. The function of the intestinal barrier was examined using FITC-dextran (FD4), TEER values, and bacterial translocation. Network pharmacology enrichment analysis revealed that Cyn could inhibit cell apoptosis. We also explored the effect and underlying mechanism of Cyn in inhibiting IEC apoptosis on intestinal barrier function and colitis using both the TNF-\u03b1-induced colonic organoid model and the TNBS-induced mouse model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our findings show that Cyn significantly alleviates TNBS-induced colitis symptoms in mice, as evidenced by reduced body weight loss, colon shortening, DAI score, colon histopathology score, and lower levels of inflammatory factors (IL-1\u03b2, TNF-\u03b1, and IL-6) compared to the model group. Additionally, the Cyn intervention group showed significant improvements in both the intestinal barrier structure (elevated tight junction protein levels and proper localization) and function (reduced serum FD4 levels, increased intestinal TEER, and decreased bacterial translocation rates in mesenteric lymph nodes [MLNs] and livers). Combining network pharmacology prediction analysis with our validation data from animal models and colonic organoids, we demonstrated that Cyn significantly inhibits IEC apoptosis, as indicated by a decrease in the proportion of TUNEL-positive cells and changes in apoptosis-related protein levels. KEGG enrichment analysis and signaling pathway intervention experiments confirmed that Cyn inhibits the activation of PI3K\/AKT signaling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Cyn inhibits IEC apoptosis by blocking the PI3K\/AKT signaling pathway, which is the primary mechanism underlying its protective effects on the intestinal barrier and its ability to improve CD-like colitis. This study also supports the potential of the Chinese medicine monomer Cyn as a promising therapeutic agent for the treatment of CD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2024.1496068","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:20:24Z","timestamp":1737339624000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Cynaroside ameliorates TNBS-induced colitis by inhibiting intestinal epithelial cell apoptosis via the PI3K\/AKT signalling pathway"],"prefix":"10.3389","volume":"15","author":[{"given":"Ju","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minzhu","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinke","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lugen","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"G119","DOI":"10.1152\/ajpgi.1995.269.1.G119","article-title":"Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs","volume":"269","author":"Appleyard","year":"1995","journal-title":"Am. J. Physiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"114337","DOI":"10.1016\/j.biopha.2023.114337","article-title":"Natural sources, biological effects, and pharmacological properties of cynaroside","volume":"161","author":"Bouyahya","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"key":"B4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/s12276-018-0126-x","article-title":"Mechanisms regulating intestinal barrier integrity and its pathological implications","volume":"50","author":"Chelakkot","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1001\/jama.2020.18936","article-title":"Management of Crohn disease: a review","volume":"325","author":"Cushing","year":"2021","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"ii30","DOI":"10.1093\/ecco-jcc\/jjac011","article-title":"Ustekinumab in Crohn's disease: new data for positioning in treatment algorithm","volume":"16","author":"D'Amico","year":"2022","journal-title":"J. Crohns Colitis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3390\/foods11071044","article-title":"Nutraceuticals and diet supplements in Crohn's disease: a general overview of the most promising approaches in the clinic","volume":"11","author":"De Conno","year":"2022","journal-title":"Foods"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3390\/ijms22031321","article-title":"Anti-inflammatory and proliferative properties of luteolin-7-O-glucoside","volume":"22","author":"De Stefano","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"153604","DOI":"10.1016\/j.phymed.2021.153604","article-title":"Cynaroside protects the blue light-induced retinal degeneration through alleviating apoptosis and inducing autophagy in vitro and in vivo","volume":"88","author":"Feng","year":"2021","journal-title":"Phytomedicine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3389\/fimmu.2019.01094","article-title":"Dysregulation of intestinal epithelial cell RIPK pathways promotes chronic inflammation in the IBD gut","volume":"10","author":"Garcia-Carbonell","year":"2019","journal-title":"Front. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e23817","DOI":"10.1096\/fj.202400211RR","article-title":"Ginkgetin improved experimental colitis by inhibiting intestinal epithelial cell apoptosis through EGFR\/PI3K\/AKT signaling","volume":"38","author":"Geng","year":"2024","journal-title":"FASEB J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature10400","article-title":"Caspase-8 regulates TNF-\u03b1-induced epithelial necroptosis and terminal ileitis","volume":"477","author":"G\u00fcnther","year":"2011","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/jrr\/rrz102","article-title":"Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, induces accumulation of DNA double-strand breaks","volume":"61","author":"Ihara","year":"2020","journal-title":"J. Radiat. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"767456","DOI":"10.3389\/fimmu.2021.767456","article-title":"IL-1\u03b2 and the intestinal epithelial tight junction barrier","volume":"12","author":"Kaminsky","year":"2021","journal-title":"Front. Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.matbio.2017.09.003","article-title":"Layilin is critical for mediating hyaluronan 35kDa-induced intestinal epithelial tight junction protein ZO-1 in vitro and in vivo","volume":"66","author":"Kim","year":"2018","journal-title":"Matrix Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1405084","DOI":"10.3389\/fimmu.2024.1405084","article-title":"Cynaroside ameliorates methotrexate-induced enteritis in rats through inhibiting NLRP3 inflammasome activation","volume":"15","author":"Lang","year":"2024","journal-title":"Front. Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"111886","DOI":"10.1016\/j.intimp.2024.111886","article-title":"Sophoricoside improved Crohn's disease-like colitis by inhibiting intestinal epithelial cell apoptosis through PI3K\/AKT signaling","volume":"131","author":"Li","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.3389\/fphar.2020.01036","article-title":"Kuijieyuan decoction improved intestinal barrier injury of ulcerative colitis by affecting TLR4-dependent PI3K\/AKT\/NF-\u03baB oxidative and inflammatory signaling and gut microbiota","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2023.07.001","article-title":"Recent advances in the treatment of IBD: targets, mechanisms and related therapies","author":"Liu","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"106146","DOI":"10.1016\/j.phrs.2022.106146","article-title":"Emerging pharmacotherapy for inflammatory bowel diseases","volume":"178","author":"Luo","year":"2022","journal-title":"Pharmacol. Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1128\/AAC.05165-14","article-title":"Autophagy inhibitors as a potential antiamoebic treatment for Acanthamoeba keratitis","volume":"59","author":"Moon","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.5009\/gnl19019","article-title":"Perspectives on current and novel treatments for inflammatory bowel disease","volume":"13","author":"Na","year":"2019","journal-title":"Gut Liver"},{"key":"B22","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.3390\/ijms23084160","article-title":"Impact of epithelial cell shedding on intestinal homeostasis","volume":"23","author":"Ngo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.5487\/TR.2018.34.2.133","article-title":"Beneficial effects of cynaroside on cisplatin-induced kidney injury in vitro and in vivo","volume":"34","author":"Nho","year":"2018","journal-title":"Toxicol. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.crohns.2011.10.004","article-title":"Anti-TNF-\u03b1 antibodies improve intestinal barrier function in Crohn's disease","volume":"6","author":"Noth","year":"2012","journal-title":"J. Crohns Colitis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S2468-1253(23)00154-1","article-title":"Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting","volume":"8","author":"Parigi","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-020-0156-2","article-title":"Crohn's disease","volume":"6","author":"Roda","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/cells8020193","article-title":"Cellular and molecular therapeutic targets in inflammatory bowel disease-focusing on intestinal barrier function","volume":"8","author":"Schoultz","year":"2019","journal-title":"Cells"},{"key":"B28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41467-018-07859-7","article-title":"Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway","volume":"10","author":"Singh","year":"2019","journal-title":"Nat. Commun."},{"key":"B29","first-page":"308","article-title":"Cell death of intestinal epithelial cells in intestinal diseases","volume":"72","author":"Subramanian","year":"2020","journal-title":"Sheng Li Xue Bao"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1002\/jcb.23121","article-title":"Protective effects of cynaroside against H\u2082O\u2082-induced apoptosis in H9c2 cardiomyoblasts","volume":"112","author":"Sun","year":"2011","journal-title":"J. Cell Biochem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"106361","DOI":"10.1016\/j.phrs.2022.106361","article-title":"Progress in the treatment of drug-induced liver injury with natural products","volume":"183","author":"Sun","year":"2022","journal-title":"Pharmacol. Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3233\/JAD-191032","article-title":"GABAB receptor-mediated PI3K\/akt signaling pathway alleviates oxidative stress and neuronal cell injury in a rat model of alzheimer's disease","volume":"76","author":"Sun","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"109681","DOI":"10.1016\/j.biopha.2019.109681","article-title":"In vivo anti-inflammatory and anti-allergic activities of cynaroside evaluated by using hydrogel formulations","volume":"121","author":"Szekalska","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"5771","DOI":"10.1002\/jcp.30261","article-title":"N-(3-oxododecanoyl)-l-homoserine lactone disrupts intestinal epithelial barrier through triggering apoptosis and collapsing extracellular matrix and tight junction","volume":"236","author":"Tao","year":"2021","journal-title":"J. Cell Physiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn's disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1053\/j.gastro.2020.08.005","article-title":"Increased intestinal permeability is associated with later development of Crohn's disease","volume":"159","author":"Turpin","year":"2020","journal-title":"Gastroenterology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/nu14050949","article-title":"The intestinal barrier dysfunction as driving factor of inflammaging","volume":"14","author":"Untersmayr","year":"2022","journal-title":"Nutrients"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1007\/s10753-018-0814-7","article-title":"Luteoloside protects the uterus from Staphylococcus aureus-induced inflammation, apoptosis, and injury","volume":"41","author":"Wang","year":"2018","journal-title":"Inflammation"},{"key":"B39","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3892\/ijo.2016.3804","article-title":"PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic cancer cells","volume":"50","author":"Wang","year":"2017","journal-title":"Int. J. Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"112799","DOI":"10.1016\/j.biopha.2022.112799","article-title":"Progress in traditional Chinese medicine and natural extracts for the treatment of lupus nephritis","volume":"149","author":"Wang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"4877275","DOI":"10.1155\/2022\/4877275","article-title":"Ruscogenins improve CD-like enteritis by inhibiting apoptosis of intestinal epithelial cells and activating Nrf2\/NQO1 pathway","volume":"2022","author":"Wen","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"153709","DOI":"10.1016\/j.phymed.2021.153709","article-title":"A recent update on the use of Chinese medicine in the treatment of inflammatory bowel disease","volume":"92","author":"Yang","year":"2021","journal-title":"Phytomedicine"},{"key":"B43","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13020-022-00633-4","article-title":"Inflammatory bowel disease: an overview of Chinese herbal medicine formula-based treatment","volume":"17","author":"Yuan","year":"2022","journal-title":"Chin. Med."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.29219\/fnr.v66.8948","article-title":"Quercetin effectively improves LPS-induced intestinal inflammation, pyroptosis, and disruption of the barrier function through the TLR4\/NF-\u03baB\/NLRP3 signaling pathway in vivo and in vitro","volume":"66","author":"Zhang","year":"","journal-title":"Food Nutr. Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"102469","DOI":"10.1016\/j.redox.2022.102469","article-title":"MPST deficiency promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel disease via AKT","volume":"56","author":"Zhang","year":"","journal-title":"Redox Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"112181","DOI":"10.1016\/j.intimp.2024.112181","article-title":"Magnolin inhibits intestinal epithelial cell apoptosis alleviating Crohn's disease-like colitis by suppressing the PI3K\/AKT signalling pathway","volume":"134","author":"Zhang","year":"","journal-title":"Int. Immunopharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e22589","DOI":"10.1096\/fj.202200234RR","article-title":"Vindoline ameliorates intestinal barrier damage in Crohn's disease mice through MAPK signaling pathway","volume":"36","author":"Zhang","year":"","journal-title":"FASEB J."},{"key":"B48","doi-asserted-by":"publisher","first-page":"155223","DOI":"10.1016\/j.phymed.2023.155223","article-title":"Arjunolic acid protects the intestinal epithelial barrier, ameliorating Crohn's disease-like colitis by restoring gut microbiota composition and inactivating TLR4 signalling","volume":"123","author":"Zhang","year":"","journal-title":"Phytomedicine"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1053\/j.gastro.2007.02.001","article-title":"R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice","volume":"132","author":"Zhao","year":"2007","journal-title":"Gastroenterology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/ecco-jcc\/jjac154","article-title":"circSMAD4 promotes experimental colitis and impairs intestinal barrier functions by targeting janus kinase 2 through sponging miR-135a-5p","volume":"17","author":"Zhao","year":"2023","journal-title":"J. Crohns Colitis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"103846","DOI":"10.1016\/j.ebiom.2022.103846","article-title":"Hypermethylation of miR-145 promoter-mediated SOX9-CLDN8 pathway regulates intestinal mucosal barrier in Crohn's disease","volume":"76","author":"Zhuang","year":"2022","journal-title":"EBioMedicine"},{"key":"B52","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1111\/jcmm.14457","article-title":"Bryostatin-1 ameliorated experimental colitis in Il-10(-\/-) Mice by protecting the intestinal barrier and limiting immune dysfunction","volume":"23","author":"Zuo","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.crohns.2014.08.008","article-title":"Cigarette smoking is associated with intestinal barrier dysfunction in the small intestine but not in the large intestine of mice","volume":"8","author":"Zuo","year":"2014","journal-title":"J. Crohns Colitis"}],"updated-by":[{"DOI":"10.3389\/fphar.2025.1591086","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000}}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1496068\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T04:27:09Z","timestamp":1743049629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1496068\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":54,"alternative-id":["10.3389\/fphar.2024.1496068"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1496068","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"article-number":"1496068"}}